The first copper(ii) complex with 1,10-phenanthroline and salubrinal with interesting biochemical properties.


Journal

Metallomics : integrated biometal science
ISSN: 1756-591X
Titre abrégé: Metallomics
Pays: England
ID NLM: 101478346

Informations de publication

Date de publication:
24 06 2020
Historique:
pubmed: 28 4 2020
medline: 10 8 2021
entrez: 28 4 2020
Statut: ppublish

Résumé

The novel copper complex [Cu(phen)2(salubrinal)](ClO4)2 (C0SAL) has been synthesised and characterised. Copper(ii) is coordinated by salubrinal through the thionic group, as shown by the UV-Vis, IR, ESI-MS and tandem mass results, together with the theoretical calculations. The formed complex showed a DPPH radical scavenging ability higher than that of salubrinal alone. Studies on lipid oxidation inhibition showed that the C0SAL concentration, required to inhibit the enzyme, was lower than that of salubrinal. The inhibition of the enzyme could take place via allosteric modulation, as suggested by docking calculations. C0SAL showed a good cytotoxic activity on A2780 cells, 82 fold higher than that of the precursor salubrinal and 1.4 fold higher than that of [Cu(phen)2(H2O)](ClO4)2. Treatment with C0SAL in SKOV3 ovarian cancer cells induced expression of GRP-78 and DDIT3 regulators of ER-stress response. The cytotoxic effect of C0SAL was reverted in the presence of TUDCA, suggesting that C0SAL induces cell death through ER-stress. In A2780 cells treated with C0SAL γ-H2AX was accumulated, suggesting that DNA damage was also involved.

Identifiants

pubmed: 32337526
doi: 10.1039/d0mt00006j
doi:

Substances chimiques

Antiviral Agents 0
Cinnamates 0
Phenanthrolines 0
salubrinal 0
Transcription Factor CHOP 147336-12-7
Taurochenodeoxycholic Acid 516-35-8
ursodoxicoltaurine 60EUX8MN5X
Copper 789U1901C5
Thiourea GYV9AM2QAG
1,10-phenanthroline W4X6ZO7939

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

891-901

Auteurs

Sebastiano Masuri (S)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Enzo Cadoni (E)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Maria Grazia Cabiddu (MG)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Francesco Isaia (F)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Maria Giovanna Demuru (MG)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Lukáš Moráň (L)

Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic and International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.

David Buček (D)

Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Petr Vaňhara (P)

Department of Histology and Embryology, Faculty of Medicine, Masaryk University, Brno, Czech Republic and International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.

Josef Havel (J)

International Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic and Department of Chemistry, Faculty of Science, Masaryk University, Brno, Czech Republic.

Tiziana Pivetta (T)

Dipartimento di Scienze Chimiche e Geologiche, Università degli Studi di Cagliari, Cittadella Universitaria, 09042 Monserrato, CA, Italy. tpivetta@unica.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH